Sorrento Therapeutics (NASDAQ:SRNE) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 12.8 % Shares of NASDAQ SRNE opened at $0.01 on Friday. Sorrento Therapeutics has a 12 month low of $0.00 and […]
More Stories
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...